Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure.
Oya
H
H
Department of Internal Medicine, Research Institute, Osaka, Japan.
Nagaya
N
N
Furuichi
S
S
Nishikimi
T
T
Ueno
K
K
Nakanishi
N
N
Yamagishi
M
M
Kangawa
K
K
Miyatake
K
K
D053607:Adrenomedullin; D000368:Aged; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D015740:Calcitonin Gene-Related Peptide / Q000008:administration & dosage / Q000627:therapeutic use*; D002302:Cardiac Output / Q000187:drug effects; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002496:Central Venous Pressure / Q000187:drug effects; D004311:Double-Blind Method; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D011863:Radioimmunoassay; D016896:Treatment Outcome
D015415:Biomarkers; D002316:Cardiotonic Agents; D010455:Peptides; D053607:Adrenomedullin; D009320:Atrial Natriuretic Factor; D015740:Calcitonin Gene-Related Peptide